Dendritic cell-based vaccines for the therapy of experimental tumors
E Pajtasz-Piasecka, M Indrová - Immunotherapy, 2010 - Future Medicine
Dendritic cells (DCs) are believed to be the most potent antigen-presenting cells able to link
the innate and adaptive immune systems. Many studies have focused on different …
the innate and adaptive immune systems. Many studies have focused on different …
Dendritic cell-based vaccine research against cancer
N Mody, S Dubey, R Sharma, U Agrawal… - Expert review of clinical …, 2015 - Taylor & Francis
Therapeutic vaccines that treat cancers with the help of the patient's own immune system
signify a feasible option for active immunotherapy against the disease. Dendritic cells (DCs) …
signify a feasible option for active immunotherapy against the disease. Dendritic cells (DCs) …
Optimizing dendritic cell-based immunotherapy for cancer
H Zhong, MR Shurin, B Han - Expert review of vaccines, 2007 - Taylor & Francis
Dendritic cells (DCs) are the most powerful professional antigen-presenting cells and are
unique in their capability to initiate, maintain and regulate the intensity of primary immune …
unique in their capability to initiate, maintain and regulate the intensity of primary immune …
Dendritic cell vaccines for cancer therapy
GM Sprinzl, L Kacani… - Cancer …, 2001 - cancertreatmentreviews.com
Dendritic cells (DC) are professional antigen-presenting cells whose primary function is the
initiation of immune response. Based on the finding that the immune system usually fails to …
initiation of immune response. Based on the finding that the immune system usually fails to …
[HTML][HTML] Distinct features of dendritic cell-based immunotherapy as cancer vaccines
C Lee, M Lee, I Rhee - Clinical and Experimental Vaccine …, 2018 - ncbi.nlm.nih.gov
Dendritic cells (DCs) are the most professional antigen presenting cells that play important
roles in connection between innate and adaptive immune responses. Numerous studies …
roles in connection between innate and adaptive immune responses. Numerous studies …
[HTML][HTML] Antitumor vaccines based on dendritic cells: from experiments using animal tumor models to clinical trials
OV Markov, NL Mironova, VV Vlassov - Acta Naturae …, 2017 - cyberleninka.ru
The routine methods used to treat oncological diseases have a number of drawbacks,
including non-specific action and severe side effects for patients. Furthermore, tumor …
including non-specific action and severe side effects for patients. Furthermore, tumor …
[HTML][HTML] Dendritic cells in cancer vaccines
P Brossart, S Wirths, W Brugger, L Kanz - Experimental hematology, 2001 - Elsevier
Dendritic cells (DC) are recognized as the most potent antigen-presenting cells with the
ability to stimulate naive resting T cells and to initiate primary immune responses …
ability to stimulate naive resting T cells and to initiate primary immune responses …
[HTML][HTML] Dendritic cells in anticancer vaccination: rationale for ex vivo loading or in vivo targeting
AV Baldin, LV Savvateeva, AV Bazhin, AA Zamyatnin Jr - Cancers, 2020 - mdpi.com
Dendritic cells (DCs) have shown great potential as a component or target in the landscape
of cancer immunotherapy. Different in vivo and ex vivo strategies of DC vaccine generation …
of cancer immunotherapy. Different in vivo and ex vivo strategies of DC vaccine generation …
Personalized dendritic cell-based tumor immunotherapy
Advances in the understanding of the immunoregulatory functions of dendritic cells (DCs) in
animal models and humans have led to their exploitation as anticancer vaccines. Although …
animal models and humans have led to their exploitation as anticancer vaccines. Although …
Advances in dendritic cell-based vaccine of cancer
Dendritic cells (DCs) are potent antigen presenting cells that exist in virtually every tissue,
and from which they capture antigens and migrate to secondary lymphoid organs where …
and from which they capture antigens and migrate to secondary lymphoid organs where …